Penske Q2 revenue beats expectations, raises dividend
Reuters2026/07/29 11:06
Overview
U.S. auto and truck retailer's Q2 revenue rose 6%, beating analyst expectations
Adjusted EPS for Q2 beat analyst expectations
Company raised quarterly dividend by 1.4% to $1.44 per share
Outlook
Company says improved freight environment is driving strong Class 8 truck order activity
Penske expects recent acquisitions to add $2 bln in estimated annualized revenue
Result Drivers
UNIT DELIVERIES - Co said 5% increase in new and used automotive units delivered was driven by resilient consumer demand and improved new vehicle availability
SERVICE AND PARTS - Service and parts gross margin improved by 80 basis points, with same-store service and parts revenue up 2% and gross profit up 3%
COMMERCIAL TRUCK MARKET - Improved freight environment led to increased Class 8 truck orders and a 5% rise in service and parts revenue in commercial truck dealerships
Company press release: ID:nPnvg8VHa
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
Beat |
$8.51 bln |
$7.98 bln (8 Analysts) |
Q2 Adjusted EPS |
Beat |
$3.62 |
$3.42 (8 Analysts) |
Q2 EPS |
|
$3.96 |
|
Q2 Net Income |
|
$261.20 mln |
|
Q2 Gross Profit |
|
$1.36 bln |
|
Q2 Operating Income |
|
$337.60 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 8 "hold" and no "sell" or "strong sell"
Wall Street's median 12-month price target for Penske Automotive Group Inc is $210.00, about 4.5% below its July 28 closing price of $220.01
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 11 three months ago
Reuters Recommended Reads
July 28 - Rush Enterprises Q2 revenue slightly beats estimates
July 28 - Asbury Automotive Q2 adjusted EPS beats estimates on used vehicle profitability
July 28 - PACCAR Q2 revenue and EPS beat expectations on strong truck orders
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin's Weirdest Trader Yet? Fly Brain Makes a Profit
Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street -- WSJ
NASDAQ TRADE HALT CONTINUES <MAMK.O> REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM